Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pheno- & Genotyping POF (WHO III)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by UMC Utrecht
Sponsor:
Collaborators:
Erasmus Medical Center
Medical Center Alkmaar
University Medical Center Groningen
Leiden University Medical Center
Medisch Spectrum Twente
Isala
Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands.
Amphia Hospital
Deventer Ziekenhuis
Catharina Ziekenhuis Eindhoven
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academisch Ziekenhuis Maastricht
VU University Medical Center
Information provided by (Responsible Party):
Bart CJM Fauser, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT01411644
First received: August 5, 2011
Last updated: December 2, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Publications: